Dr. Reddy's GAAP EPS of ?14.52, revenue of ?87.27B
Source: SeekingAlpha
2026-01-21 23:38:58 ET
More on Dr. Reddy's
- Dr. Reddy's Laboratories Limited (RDY) Q3 2026 Earnings Call Transcript
- Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds
- Dr. Reddy's Laboratories Limited (RDY) Q2 2026 Earnings Call Transcript
- Dr. Reddy's wins India nod for generic Ozempic
- Seeking Alpha’s Quant Rating on Dr. Reddy's
Read the full article on Seeking Alpha
For further details see:
Dr. Reddy's GAAP EPS of ?14.52, revenue of ?87.27B
Dr. Reddy's Laboratories Ltd
NASDAQ: RDY
RDY Trading
-0.8% G/L:
$14.235 Last:
784,033 Volume:
$14.23 Open:
RDY Latest News
February 20, 2026 10:57:00 am
Dr. Reddy's Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
RDY Stock Data
$11,719,925,601
612,073,010
N/A
98
N/A
Pharmaceuticals
Healthcare
IN
Hyderabad
